At a glance
Annual meetings for the NCHHSTP Epidemiologic and Economic Modeling Agreement offer educational sessions, network opportunities, and the latest resources to improve the effectiveness of public health programs and activities.
Jul 19-21, 2022
10:00 AM - 4:00 PM ET
Meeting agenda: July 19, 2022
HIV
- Welcome and Introductions: Michelle Van Handel (OD)
- Overview of division priorities and reflections: Demetre Daskalakis (DHP)
- Evaluation of testing and linkage interventions targeted to network partners of men who have sex with men (MSM) - Presenter: Samuel Jenness, Emory University/Coalition for Applied Modeling and Prevention
(CAMP) - Impact of social distancing and stay at home orders on risk behaviors, provision and receipt of prevention/care services, and HIV transmission - Presenter: Steven Goodreau, University of Washington/CAMP
- Impact of racial and ethnic disparities on achievement of Ending the HIV Epidemic (EHE) goals - Presenter: Deven Hamilton, University of Washington/CAMP
- Estimation of pre-exposure prophylaxis (PrEP) need among demographic strata in the US adults and adolescents - Presenter: Minttu Rönn, Stanford University/ Prevention Policy Modeling Lab
(PPML)
- Follow-up discussion and wrap-up for HIV (Closed meeting with NEEMA collaborators)
- Break
Adolescent and school health
- Welcome and Introductions: Taiwo Abimbola (OD)
- Overview of division priorities and reflections
- County-level estimates of sexually active adolescents - Presenter: Deepa Jahagirdar, Stanford University /PPML
- Impact of Racial and Ethnic Disparities on Achievement of Ending the HIV Epidemic (EHE) goals (adolescents) - Presenter: Deven Hamilton, University of Washington/CAMP
- Health and economic impact of 10-year sexual risk behavior change among U.S. high school students: pregnancies - Presenter: Steven Goodreau, University of Washington/CAMP
- Follow-up discussion and wrap-up for Adolescent and School Health (Closed meeting with NEEMA collaborators)
Meeting agenda: July 20, 2022
Multi-division*
- Welcome and Introductions / Overview: Taiwo Abimbola (OD)
- Optimizing routine screening for HIV, viral hepatitis, STIs, and TB in clinical settings - Presenter: Lucia Cillioni, Johns Hopkins University/CAMP
- Quantifying health and economic gains from attaining health equity targets in viral hepatitis, TB and STIs - Presenters: Joshua Salomon, Minttu Rönn, and Yunfei Li Stanford
- Wrap-up and reflections
- Break
*multi-division: modeling activity involving multiple diseases/topics and representing all NCHHSTP divisions.
Tuberculosis
- Welcome and Introductions: Taiwo Abimbola (OD)
- Overview of division priorities
- Model-based analysis of tuberculosis genotype clusters in the United States and across California, Florida, New York, and Texas; Modeling predictors of growth in large outbreaks - Presenter: Sourya Shrestha and Lucia Cillioni, Johns Hopkins University/CAMP
- Racial/ethnic disparities in TB disease outcomes in the United States - Presenter: Mathilda Regan (Stanford/PPML)
- Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States - Presenter: Sun Kim/Nick Menzies, Harvard University/PPML
- Exploring the potential impact of the COVID-19 pandemic on future TB in the United States - Presenter: Nicole Swartwood, Harvard University/PPML
- Wrap-up and Director’s reflections
Meeting agenda: July 21, 2022
STD
- Welcome and Introductions: Taiwo Abimbola (OD)
- Overview of division priorities and reflections: Tom Gift (DSTDP)
- Engaging internal and external stakeholders in the design, development, and dissemination of STD modeling tools - Presenter: Erika Martin, University at Albany SUNY/CAMP
- Estimating the Cost-Effectiveness and HIV Impact of Screening men who have sex with men (MSM) for Chlamydia and Gonorrhea - Presenter: Jeb Jones, Emory University/CAMP
- Modeling diagnostics and decision rules for addressing antimicrobial resistant gonococcal infection - Presenter: Reza Yaesoubi and Xuecheng Yin, Yale University/PPML
- Estimating the cost-effectiveness of chlamydia screening in women and men who have sex with women (MSW) - Presenter: Minttu Rönn, Stanford University/PPML
- Follow-up discussion and wrap-up for STD (Closed meeting with NEEMA collaborators
- Break
Viral hepatitis
- Welcome and Introductions: Taiwo Abimbola (OD)
- Overview of division priorities and reflections
- Hepatitis B cascade of care: current status and cost-effectiveness of improvements - Presenter: David Hutton, University of Michigan/PPML
- Expanding hepatitis C screening among persons who inject drugs (PWID) towards hepatitis C elimination - Presenter: Lin Zhu, Stanford University/PPML
- Evaluating effectiveness and cost-effectiveness of different timing and testing approaches for infants perinatally exposed to hepatitis C virus - Presenter: Eric Hall, Oregon Health and Sciences University/CAMP
- Estimated number of people who inject drugs (PWID) in the United States - Presenter: Heather Bradley, Georgia State University/CAMP
- Follow-up discussion and wrap-up for Viral Hepatitis (Closed meeting with NEEMA collaborators)